Le Lézard
Classified in: Health
Subjects: PET, ANW

TECHLAB® Receives USDA Establishment License And Product License For GIARDIA VET CHEKtm


BLACKSBURG, Va., Nov. 8, 2017 /PRNewswire/ -- TECHLAB, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEKtm. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the first USDA licensed Giardia microwell ELISA available in the US veterinary market. 

 (PRNewsfoto/TECHLAB, Inc.)

"The GIARDIA VET CHEKtm allows for large-scale testing of canine and feline in a reference laboratory format; improving workflow and providing timely results," said Joel Herbein, Vice-President of Scientific Affairs at TECHLAB, Inc.

Giardia is a common parasitic cause of diarrhea in dogs and cats.1 The GIARDIA VET CHEKtm test is an automatable enzyme immunoassay optimized for canine and feline fecal samples to aid in the diagnosis of giardiasis. The GIARDIA VET CHEKtm test is the first TECHLAB, Inc. product to be manufactured under the USDA establishment license. 

About TECHLAB®
TECHLAB, Inc. (www.techlab.com) has been a leading developer and manufacturer of intestinal diagnostics products in the United States for 27 years. The Company has a market leading portfolio of diagnostic tests for enteric diseases caused by C. difficile, Shiga toxin producing E. coli, and protozoan parasites. TECHLAB also manufactures diagnostic tests for intestinal inflammation and performs diagnostics and life science contract manufacturing and services. TECHLAB is headquartered in Blacksburg, Va. and manufactures its diagnostic tests in the United States at its state-of-the-art manufacturing facility in Radford, Va.

References
1.  The Merck Veterinary Manual. Overview of giardiasis. United States: Merck; 2016

SOURCE TECHLAB, Inc.


These press releases may also interest you

at 06:45
The "Global Pediatric Interventional Cardiology Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to  ResearchAndMarkets.com's offering. The Global Pediatric...

at 06:30
The "Sample Preparation Market by Product (Workstation, Instrument {Pipette, Washer, Centrifuge, Grinder}, Consumable {Kits, Filters, Plates}) Technique (Solid Phase Extraction, Purification) Application (Drug Discovery, Diagnostic) - Global Forecast...

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...



News published on and distributed by: